Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Access:

Availability:

Participation Type:

Categories:

Browse by: Sort by:
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 31
Chair
Zeynep Madak Erdogan, PhD
UIUC, Urbana, IL
In Utero Exposure to 17α-Hydroxyprogesterone Caproate May Contribute to Increasing Incidence Rates of Early-Onset Cancer
Caitlin Murphy, PhD, MPH
University of Texas Southwestern Medical Center, Dallas, TX
Audience Q&A
Perchlorate and Nitrate Treatments Disrupt the Endoderm and Thyroid Development Through Epigenetic Mechanisms
Caroline Serrano-Nascimento, PhD
UNIFESP, Sao Paulo, Brazil
Audience Q&A
Novel Assay for Detection of Progesterone Receptor-Interacting Endocrine Disruptors
Diana Stavreva, PhD
NIH, NCI-CCR, Bethesda, MD
Audience Q&A
Disruption of Estrogenic and Androgenic Bioactivities in Human Fetuses Exposed to Maternal Smoking
Chiara Talia, DVM
University of Aberdeen, Aberdeen, United Kingdom
Audience Q&A
from ENDO 2021 on March 23, 2021 11:00 AM-12:00 PM
Opiate Addiction: Neuroendocrine and Genetic Aspects of this Disease and of its Treatment.
Gavin Bart, MD, PhD
Hennepin Healthcare, Minneapolis, MN
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
The Gut-Brain Endocrine System in Food Reward and Addiction
Anthony P Goldstone, PhD
Imperial College London, London, United Kingdom
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Dopamine Agonists and the Induction of Addictive Behaviors in Endocrine Disease
Ashley Grossman, MD
Churchill Hospital, London, United Kingdom
from ENDO 2019 on March 26, 2019 8:00 AM-9:30 AM
Emerging Iatrogenic Endocrinopathies - Checkpoint Inhibitors/TK Inhibitors
Ramona Dadu, MD
The Univ of Texas MD Anderson Cancer Ctr, Houston, TX
from ENDO 2018 on March 19, 2018 2:00 PM-2:45 PM
Assessing the Risk of Exposure of Humans to EDCs during Fetal Development
Rod Mitchell, MBChB, BSc, PhD
University of Edinburgh, Edinburgh, United Kingdom
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Endocrine Disrupting Activity of Associated with Oil and Gas Extraction
Susan Carol Nagel, PhD
University of Missouri, Columbia, MO
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Clarity of EDCs in the Face of Confusion
Laura N Vandenberg, PhD
Tufts Univ Schl of Med, Boston, MA
from ENDO 2017 on April 1, 2017 4:30 PM-6:00 PM
Interactive Learning about Endocrine Disrupting Chemicals: Your Vote Counts
Jean-Pierre J Bourguignon, MD,PHD
Univ of Liège, Liège, Belgium
R Thomas Zoeller, MS, PhD
Univ of Massachusetts, Amherst, MA
from ENDO 2016 on April 1, 2016 2:15 PM-3:45 PM
Award Presentations
Lisa H Fish, MD
Hennepin County Medical Ctr, Edina, MN
from ENDO 2016 on April 3, 2016 10:00 AM-11:15 AM
Discovering the Genetic Architecture of Endocrine Systems Using Human Disease Models: A Journey from Mendel to Populations
William F Crowley, Jr., MD
Massachusetts General Hospital, Boston, MA
from ENDO 2016 on April 3, 2016 10:00 AM-11:15 AM
Diet-Induced Paternal Obesity and Transgenerational Alterations of Reproductive Health
Michelle Lane, PhD
University of Adelaide, Adelaide, Australia
from ENDO 2015 on March 6, 2015 9:30 AM-11:00 AM
Epigenetic Basis of Mammary and Testicular Development: Interaction of Diet and Environmental Exposures
Shuk-Mei Ho, PhD
University of Cincinnati, Cincinnati, OH
from ENDO 2015 on March 6, 2015 9:30 AM-11:00 AM
Effects of Developmental Exposure to Bisphenol A on Brain and Behavior in Mice
Emilie F Rissman, PHD
Univ of Virginia Schl of Med, Charlottesville, VA
from ENDO 2015 on March 6, 2015 9:30 AM-11:00 AM
Developmental Estrogen Exposure Alters the Epigenetic Landscape of the Female Reproductive Tract
Carmen J Williams, MD,PhD
NIH / NIEHS, Research Triangle Park, NC
from ENDO 2015 on March 7, 2015 9:30 AM-11:00 AM
Estrogens, the Heart and Endocrine Disruptors
Hong-Sheng Wang, PHD
University of Cincinnati, Cincinnati, OH
from ENDO 2015 on March 7, 2015 9:30 AM-11:00 AM
Estrogen and Epigenetic Stability in the Uterine Fibroid
Antonia Navarro, PhD
Northwestern Univ, Chicago, IL
from ENDO 2015 on March 7, 2015 9:30 AM-11:00 AM
Development of Endocrine Adverse Outcome Pathways (AOPs) And Associated Testing Strategies Identifying Chemicals' Potential for Endocrine Disruption
David J. Dix, PhD
U.S. Environmental Protection Agency, Washington, DC
from ENDO 2015 on March 7, 2015 2:15 PM-3:15 PM
Endocrine Society's New EDC Scientific Statement: Do we have a Critical Mass of Science?
Andrea C Gore, PhD
University of Texas at Austin, Austin, TX
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
The Economic Costs of EDCs
Leonardo Trasande, MD, MPP
NYU School of Medicine, New York, NY
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
Contrasting Perspectives on EDCs from Different Science Domains - Basic Endocrinology
R Thomas Zoeller, MS, PhD
Univ of Massachusetts, Amherst, MA
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
Contrasting Perspectives on EDCs from Different Science Domains: Clinical Endocrinology
Jorma Toppari, MD, PhD
University of Turku, Turku, Finland
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
Contrasting Perspectives on EDCs from Different Science Domains: Regulatory Needs
David J Dix, PhD
U.S. Environmental Protection Agency, Washington, DC
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
Questions and Answers
Jean-Pierre J Bourguignon, MD,PHD
Univ of Liège, Liège, Belgium
R Thomas Zoeller, MS, PhD
Univ of Massachusetts, Amherst, MA
Jorma Toppari, MD, PhD
University of Turku, Turku, Finland
David J Dix, PhD
U.S. Environmental Protection Agency, Washington, DC
from ENDO 2015 on March 7, 2015 4:30 PM-6:30 PM
Endocrine Disruptors & Childhood Growth & Development
Sara A DiVall, MD
Johns Hopkins Univ, Baltimore, MD
from ICE/ENDO 2014 on June 22, 2014 9:30 AM-11:00 AM
<< first | < prev page: of 2 records per page: next > | last >>
pages: 1 2 presentations: 1 to 25 of 31